Final report on the safety assessment of arnica Montana extract and arnica Montana

International Journal of Toxicology

Volumn 20, Issue 2_suppl, 2001, Pages 1-11

  Fiume, Monice Zondlo ^a  

^a NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL DERIVATIVE; ARNICA MONTANA EXTRACT; ARNICIN; BUTANEDIOL; CARBOHYDRATE; CAROTENOID; CHOLINE; COUMARIN DERIVATIVE; ESSENTIAL OIL; FATTY ACID; FLAVONOID; HEAVY METAL; INULIN; LINOLEIC ACID; LINOLENIC ACID; MYRISTIC ACID; PALMITIC ACID; PHENOL; PHULIN; PHYTOSTEROL; PROPYLENE GLYCOL; RESIN; SESQUITERPENE LACTONE; SOYBEAN OIL; TANNIN DERIVATIVE; TRITERPENIC ALCOHOL DERIVATIVE; UNCLASSIFIED DRUG; COSMETIC; PLANT EXTRACT;

ABSORPTION; ACUTE TOXICITY; AMES TEST; ANALYTIC METHOD; ARNICA MONTANA; ARTICLE; CARCINOGENICITY; CHEMICAL COMPOSITION; CLINICAL ASSESSMENT; CYTOTOXICITY; DEATH; DERMATITIS; DEVELOPMENTAL TOXICITY; DRUG IMPURITY; DRUG MANUFACTURE; EXCRETION; EYE IRRITATION; FLOWER; GASTROENTERITIS; GENOTOXICITY; HISTOPATHOLOGY; HUMAN; LIGHT ABSORPTION; METABOLISM; MUSCLE WEAKNESS; MUTAGENICITY; NERVOUSNESS; NONHUMAN; PARTICLE SIZE; PHOTOSENSITIZATION; PHOTOTOXICITY; PHYSICAL CHEMISTRY; PLANT GROWTH; REPRODUCTIVE TOXICITY; RISK ASSESSMENT; SKIN ALLERGY; SKIN IRRITATION; SKIN SENSITIZATION; TOXICITY TESTING; ULTRAVIOLET A RADIATION; ULTRAVIOLET B RADIATION; ANIMAL; CARCINOGEN TESTING; CHEMICALLY INDUCED DISORDER; CHEMISTRY; DRUG EFFECT; GUINEA PIG; HEART RATE; INTRADERMAL DRUG ADMINISTRATION; MOUSE; PHOTOCHEMISTRY; RABBIT; RAT; REVIEW; SAFETY; ULTRAVIOLET RADIATION;

ADMINISTRATION, CUTANEOUS; ANIMALS; ARNICA; CARCINOGENICITY TESTS; COSMETICS; GASTROENTERITIS; GUINEA PIGS; HEART RATE; HUMANS; MICE; MUSCLE WEAKNESS; PHOTOCHEMISTRY; PLANT EXTRACTS; RABBITS; RATS; SAFETY; TOXICITY TESTS; ULTRAVIOLET RAYS;

EID: 0035225961     PISSN: 10915818     EISSN: 1092874X     Source Type: Journal    
DOI: 10.1080/1091581015290254711     Document Type: Article

References (59)

1. Bruynzeel, D. P., W. G. van Ketel, E. Young, T. van Joost, and G. Smeenk. 1992. Contact sensitization by alternative topical medicaments containing plant extracts. Contact Dermatitis 27: 278-279.
2. Budavari, S., ed. 1989. The Merck index. An encyclopedia of chemicals, drugs, and biologicals, 11th ed., 124-125. Rahway, NJ: Merck & Co., Inc.
3. Chemisches Laboratorium Dr. Kurt Richter GmbH. 1996. Raw material documentation on Arnica Oil CLR (Arnica Montana Extract and soybean (Glycine Soja) oil and tocopherol). Unpublished data submitted by CTFA. (7 pages.)4
4. Chemline. 1996. Online printout from the National Library of Medicine (NLM) database. Bethesda, MD: NLM.
5. Consumer Product Testing. 1977. Ocular irritation study using rabbits of Arnica Oil CLR. Experiment Reference No. 77255-2. Final report dated Aug 29. Unpublished data submitted by CTFA. (6 pages.)4
6. Cosmetic, Toiletry, and Fragrance Association (CTFA). 1981. Acute oral toxicity, skin irritation, sensitization, and ocular irritation testing on Arnica Montana Extract. Unpublished data submitted by CTFA. (27 pages.)4
7. CTFA. No date. Repeated insult patch test of a skin cream containing 1% of a mixture of Arnica Montana Extract and Sunflower (Helianthus Annuus) Seed Oil. Unpublished data submitted by CTFA. (6 pages.)4
8. CTFA. 1986. Skin irritation, ocular irritation, and human patch testing on a mixture of Arnica Montana Extract and Sunflower (Helianthus Annuus) Oil. Unpublished data submitted by CTFA. (6 pages.)4
9. CTFA. 1988. A clinical 4-day mini-cumulative irritancy test of a body cream (73965-04) containing 1.0% of a mixture of Arnica Montana Extract and Sunflower (Helianthus Annuus) Oil. Study Ref. No. 554-88. Unpublished data submitted by CTFA. (1 page.)4
10. CTFA. 1998. Concentration of use data on Arnica Montana Extract. Unpublished data submitted by CTFA. (1 page.)4
11. Cosmetics Directive of the European Union. 1995. Updated version-Incorporating all amendments until August 1, 1995. Dir. 76/768/EEC.
12. de Groot, A. C., D. P. Bruynzeel, J. D. Bos, et al. 1988. The allergens in cosmetics. Arch. Dermatol. 124: 1525-1529.
13. Duke, J. A. 1985. CRC handbook of medicinal herbs, 64-65. Boca Raton, FL: CRC Press.
14. Fernandez de Corres, L. 1984. Contact dermatitis from frullania, compositae and other plants. Contact Dermatitis 11: 74-79.
15. Food and Drug Administration (FDA). 1984. Cosmetic product formulation and frequency of use data. FDA computer printout. Washington, DC: FDA.
16. FDA. 1992. Modification in voluntary filing of cosmetic product ingredient and cosmetic raw composition statements. Fed. Register 57: 3128-3130.
17. FDA. 1997. Natural flavoring substances and natural substances used in conjunction with flavors. Code of Federal Regulations, Title 21, §172.510.
18. FDA. 1998. Frequency of use of cosmetic ingredients. FDA computer printout. Washington, DC: FDA.
19. Göggelmann, W. 1986. Investigations on the mutagenicity of plant preparations and medicines in Salmonella typhimurium. Mutat. Res. 164: 291.
20. Göggelmann, W., and O. Schimmer. 1986. Mutagenic activity of phytotherapeutical drugs. Prog. Clin. Biol. Res. 206: 63-72.
21. Góra, J., D. Kalemba, A. Kurowska, and L. Swaitek. 1980. Chemical substances from influorescences of Arnica montana L. and Calendula officinalis L. soluble in isopropyl myristate and propylene glycol. Herba Hung. 19: 165-171.
22. Grant, J., ed. 1972. Hackh's chemical dictionary, 4th ed., 60. New York: McGraw-Hill.
23. Grau Aromatics GmbH & Co. 1997. Specifications of Arnica Extract HS 2397 G (Arnica Montana Extract and propylene glycol). Unpublished data submitted by CTFA. (1 page.)4
24. Hausen, B. M. 1978. Identification of the allergens of Arnica montana L. Contact Dermatitis 4: 308.
25. Hausen, B. M. 1979. The sensitizing capacity of Compositae plants. III. Test results and cross-reactions in Compositae-sensitive patients. Dermatologica 159: 1-11.
26. Hausen, B. M. 1980. Arnica allergy. Der Hautarzt 31: 10-17.
27. Hausen, B. M. 1996. A 6-year experience with Compositae mix. Am. J. Contact Dermatitis 7: 94-99.
28. Hausen, B. M., H. D. Herrmann, and G. Willuhn. 1978. The sensitizing capacity of Compositae plants. I. Occupational contact dermatitis from Arnica longifolia Eaton. Contact Dermatitis 4: 3-10.
29. Henkel Corporation. 1997. Correspondence regarding the amount of Arnica Montana Extract in Arnica Oil CLR. Unpublished data submitted by CTFA. (3 pages.)4
30. Herrmann, H-D., G. Willuhn, and B. M. Hausen. 1978. Helenalinmethacrylate, a new pseudoguaianolide from the flowers of Arnica montana L. and the sensitizing capacity of their sesquiterpene lactones. Planta Med. 34: 299-304.
31. Ichimaru Pharcos Co., Ltd. 1995. Specifications of Arnica Liquid (Arnica Montana Extract and butylene glycol and water). Unpublished data submitted by CTFA. (5 pages.)4
32. International Bio-Research, Inc. (IBR). 1972a. Acute oral toxicity test of Arnica Oil-CLR on rats. Study dated July 18. Unpublished data submitted by CTFA. (6 pages.)4
33. IBR. 1972b. Examination of Arnica Oil in the eye irritation test on rabbits. Study dated June of 1972. Unpublished data submitted by CTFA. (9 pages.)4
34. IBR. 1976. Patch test for primary skin irritation and corrosivity of the compound: "Arnicaöl CLR" (10% paraffin oil solution). Study dated December of 1976. Unpublished data submitted by CTFA. (7 pages.)4
35. IBR. 1977. Investigation of sensitising effects on guinea pigs of "Arnicaöl CLR" (undiluted). Study dated May of 1977. Unpublished data submitted by CTFA. (6 pages.)4
36. Ivy Laboratories-KGL. 1988. The determination of the contact sensitizing potential of a face cream (39607-22) containing 1% of a mixture of Arnica Montana Extract and Sunflower (Helianthus Annuus) Oil by mean of the maximization test. Final report dated April 22 of 1988. Unpublished data submitted by CTFA. (12 pages.)4
37. Leung, A. Y. 1980. Encyclopedia of common natural ingredients used in foods, drugs, and cosmetics, 34-35. Toronto: John Wiley & Sons.
38. Machet, L., L. Vaillant, A. Callens, M. Demasure, K. Barruet, and G. Lorette. 1993. Short communication. Allergic contact dermatitis from sunflower (Helianthus annuus) with cross-sensitivity to arnica. Contact Dermatitis 28: 184-200.
39. MacKinnon, S. 1992. Arnica montana. Can. Pharm. J. 125: 125-126, 128.
40. Nikitakis, J. M., and G. N. McEwen Jr, eds. 1990. CTFA compendium of cosmetic ingredient composition-descriptions I. Washington, DC: CTFA.
41. Paulsen, E., K. E. Andersen, and B. M. Hausen. 1993. Compositae dermatitis in a Danish dermatology department in one year. Contact Dermatitis 29: 6-10.
42. Pietta, P. G., P. L. Mauri, A. Bruno, and I. Merfort. 1994. MEKC as an improved method to detect falsifications in the flowers of Arnica montana and A. chamissonis. Planta Med. 60: 369-372.
43. Pirker, C., T. Möslinger, D. Y. Koller, M. Götz, and R. Jarisch. 1992. Cross-reactivity with Tagetes in Arnica contact eczema. Contact Dermatitis 26: 217-219.
44. Puhlmann, J., M. H. Zenk, and H. Wagner. 1991. Immunologically active polysaccharides of Arnica montana cell cultures. Phytochemistry 30: 1141-1145.
45. Registry of the Toxic Effects of Chemical Substances (RTECS). 1996. Online printout from the NLM database. Bethesda, MD: NLM.
46. Rempe, J. M., and L. G. Santucci. 1997. CTFA list of Japanese cosmetic ingredients, 3rd ed., 9. Washington, DC: CTFA.
47. Research Institute for Fragrance Materials, Inc. (RIFM). 1996a. Monograph 1121-Arnica resinoid. Hackensack, NJ.
48. RIFM. 1996b. Monograph 1240-Arnica absolute. Hackensack, NJ.
49. Rodriquez, E., and J. C. Mitchell. 1977. Absence of contact hypersensitivity to some perfume materials derived from Compositae species. Contact Dermatitis 3: 168-169.
50. Rossetti, V., A. Lombard, P. Sancin, and M. Buffa. 1987. Characterization of Arnica montana L. flowers. Boll. Chim. Farm. 126: 458-461.
51. Rudzki, E., and Z. Grzywa. 1977. Dermatitis from Arnica montana. Contact Dermatitis 3: 281-282.
52. Schröder, H., W. Lösche, H. Strobach, et al. 1990. Helenalin and 11α13-dihydrohelenalin, two constituents from Arnica montana L., inhibit human platelet function via thiol-dependent pathways. Thromb. Res. 57: 839-845.
53. Wagner, V. H., A. Proksch, I. Riess-Maurer, et al. 1985. Immunostimulating polysaccharides (heteroglycans) from higher plants. Arzneim. Forsch. 35: 1069-1075. (Translated from German.)
54. Wenninger, J. A., and G. N. McEwen Jr, eds. 1997. CTFA international cosmetic ingredient dictionary and handbook, 7th ed., Vol. 1, 88-89. Washington, DC: CTFA.
55. Willuhn, G. 1986. Arnica contact dermatitis and the contact allergens causing it. Deutsche Apotheker. Zeitung 126: 3038-3044. (Translated from German.)
56. Willuhn, G. 1991. Arnica montana L.-Portrait of a medicinal plant. Pharm. Ztg. 136: 9-12, 14, 18, 21, 24-26. (Translated from German.)
57. Willuhn, G., W. Leven, and C. Luley. 1994. Arnica flower DAB 10. Studies of qualitative and quantitative variability of sesquiterpene lactone content of medicinal arnica drugs. Deutsche Apotheker. Zeitung 134: 49-50, 52, 55-56, 58-59. (Translated from German.)
58. Woerdenbag, H. J., I. Merfort, C. M. Paßreiter, et al. 1994. Cytotoxicity of flavonoids and sesquiterpene lactones from Arnica species against the GLC4 and the COLO 320 cell lines. Planta Med. 60: 434-437.
59. Wrangsjö K., A. M. Ros, and J. E. Wahlberg. 1990. Contact allergy to Compositae plants in patients with summer-exacerbated dermatitis. Contact Dermatitis 22: 148-154.